Iladatuzumab (MCDS0593A) is a humanized IgG1 anti-human CD79B monoclonal antibody. Iladatuzumab can be used to synthesize antibody-drug conjugates (ADC) Iladatuzumab vedotin (DCDS0780A, HY-P99657), which has the potential for B-cell non-Hodgkin lymphoma (B-NHL) research[1][2].
Molecular Weight:
(145.18 kDa)
Purity:
96.97
CAS Number:
[1906205-76-2]
Target:
ADC Antibody
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted